[stock-market-ticker symbols="AAPL;MSFT;GOOG;HPQ;^SPX;^DJI;LSE:BAG" stockExchange="USA" width="100%" palette="financial-light"]

Food & Health

fileName-GSKs-Hepatitis-B-Drug-Meets-Primary-Goals-in-Phase-III-Trials-1767794969640
GSK's Hepatitis B Drug Meets Primary Goals in Phase III Trials
GSK (GSK.L) announced its experimental hepatitis B treatment bepirovirsen met primary endpoints in two phase III studies, advancing regulatory filing plans. The positive results for the potential first-in-class therapy could address a significant unmet medical need for chronic...
fileName-Incyte-Blood-Cancer-Drug-Meets-Key-Trial-Goal-Shares-Rise-2
Incyte Blood Cancer Drug Meets Key Trial Goal, Shares Rise 2.3%
Incyte (INCY.O) shares jumped 2.3% Monday after its experimental blood cancer combination therapy met...
Novo Nordisk Launches Wegovy Weight-Loss Pill at 149 Monthly for Self-Pay Patients
Novo Nordisk (NVO) launched its oral Wegovy weight-loss pill Sunday at 149 monthly for self-pay patients, marking the first GLP-1 obesity pill in the...
Ultragenyx Shares Plunge After Bone Disease Drug Fails Late-Stage Trials
AstraZeneca's Lung Cancer Drug Combo Fails Late-Stage Trial, Shares Drop 1%
Krispy Kreme Sells Japan Operations to Unison Capital for 65 Million
Trump Set to Announce Additional Drug-Pricing Deals with Pharmaceutical Companies
Roche Breast Cancer Drug Cuts Recurrence Risk 30% in Phase III Trial
fileName-campbell-s-beats-q1-sales-estimates-on-resilient-packaged-food-demand-1765289009433
Campbell's Beats Q1 Sales Estimates on Resilient Packaged Food Demand
Dateline: NEW YORK, December 9, 2025 – Campbell Soup Co (CPB) exceeded first-quarter sales estimates with 2.7 billion in revenue, beating analyst expectations of 2.66 billion...
fileName-moderna-completes-us-mrna-manufacturing-network-with-140-million-investment-1763560904817
Moderna Completes US mRNA Manufacturing Network With 140 Million Investment
Dateline: CAMBRIDGE, Mass., November 19, 2024 – Moderna (MRNA.O) will invest over 140 million to complete its domestic mRNA manufacturing network, enabling full end-to-end...
fileName-sanofi-s-type-1-diabetes-drug-wins-eu-panel-recommendation-1763128922048
Sanofi's Type 1 Diabetes Drug Wins EU Panel Recommendation
Dateline: PARIS, November 14, 2025 – Sanofi (SNY.PA) gained European regulatory backing for its first-of-its-kind diabetes drug that delays disease onset in high-risk patients. The...
fileName-bristol-myers-j-j-halt-heart-drug-trial-after-interim-analysis-shows-poor-results-1763129107913
Bristol Myers, J&J Halt Heart Drug Trial After Interim Analysis Shows Poor Results
Dateline: NEW YORK, November 14, 2025 – Bristol Myers Squibb (BMY) and Johnson & Johnson (JNJ) halted a late-stage heart drug trial after interim analysis showed the...
fileName-biontech-reassures-investors-as-pfizer-partnership-remains-intact-1763042625343
BioNTech Reassures Investors as Pfizer Partnership Remains Intact
Dateline: FRANKFURT, November 13, 2024 – BioNTech (BNTX) confirmed its collaboration with Pfizer (PFE) remains unchanged amid speculation about potential changes to their...
MORE NEWS
fileName-tyson-foods-forecasts-annual-revenue-rise-as-chicken-demand-offsets-beef-woes-1762783557000
Tyson Foods Forecasts Annual Revenue Rise as Chicken Demand Offsets Beef Woes
fileName-treehouse-foods-surges-20-on-2-9-billion-buyout-deal-1762783732614
TreeHouse Foods Surges 20% on 2.9 Billion Buyout Deal
fileName-gilead-s-trodelvy-fails-late-stage-breast-cancer-study-shares-fall-1762524143523
Gilead's Trodelvy Fails Late-Stage Breast Cancer Study, Shares Fall
CATEGORIES